These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15764183)

  • 1. Favorable prognosis of Staphylococcus aureus bacteremia originating from soft tissues: a prospective study of fifty cases.
    Khosrovaneh A; Sharma M; Khatib R
    Scand J Infect Dis; 2005; 37(1):6-10. PubMed ID: 15764183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection.
    Khatib R; Riederer K; Saeed S; Johnson LB; Fakih MG; Sharma M; Tabriz MS; Khosrovaneh A
    Clin Infect Dis; 2005 Sep; 41(5):594-8. PubMed ID: 16080079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome.
    Khatib R; Johnson LB; Fakih MG; Riederer K; Khosrovaneh A; Shamse Tabriz M; Sharma M; Saeed S
    Scand J Infect Dis; 2006; 38(1):7-14. PubMed ID: 16338832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology, course and prognosis of Staphylococcus aureus bacteremia--Preliminary results from the INSTINCT (INvasive STaphylococcus aureus INfection CohorT) cohort].
    Seifert H; Wisplinghoff H; Kaasch A; Achilles K; Langhorst A; Peyerl-Hoffmann G; Woehrmann A; Fätkenheuer G; Salzberger B; Kern WV
    Dtsch Med Wochenschr; 2008 Feb; 133(8):340-5. PubMed ID: 18270913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
    Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
    Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
    Khatib R; Johnson LB; Sharma M; Fakih MG; Ganga R; Riederer K
    Scand J Infect Dis; 2009; 41(1):4-9. PubMed ID: 18821135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality.
    Mokrzycki MH; Zhang M; Cohen H; Golestaneh L; Laut JM; Rosenberg SO
    Nephrol Dial Transplant; 2006 Apr; 21(4):1024-31. PubMed ID: 16449293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
    Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
    Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
    Laupland KB; Ross T; Gregson DB
    J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
    Lederer SR; Riedelsdorf G; Schiffl H
    Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
    Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
    Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group A streptococcal bacteremia: outcome and prognostic factors.
    Vallalta Morales M; Soriano Navarro CJ; Salavert Lletí M; Montero Alonso M; Pérez Bellés C; López Aldeguer J; Otero MC; Gobernado Serrano M
    Rev Esp Quimioter; 2006 Dec; 19(4):367-75. PubMed ID: 17235407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical identifiers of complicated Staphylococcus aureus bacteremia.
    Fowler VG; Olsen MK; Corey GR; Woods CW; Cabell CH; Reller LB; Cheng AC; Dudley T; Oddone EZ
    Arch Intern Med; 2003 Sep; 163(17):2066-72. PubMed ID: 14504120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients.
    Ruotsalainen E; Sammalkorpi K; Laine J; Huotari K; Sarna S; Valtonen V; Järvinen A
    BMC Infect Dis; 2006 Sep; 6():137. PubMed ID: 16965625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature.
    Zinkernagel AS; Zinkernagel MS; Elzi MV; Genoni M; Gubler J; Zbinden R; Mueller NJ
    Infection; 2008 Aug; 36(4):314-21. PubMed ID: 18648747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.
    Ruotsalainen E; Järvinen A; Koivula I; Kauma H; Rintala E; Lumio J; Kotilainen P; Vaara M; Nikoskelainen J; Valtonen V;
    J Intern Med; 2006 Feb; 259(2):179-90. PubMed ID: 16420547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus aureus bloodstream infections: definitions and treatment.
    Corey GR
    Clin Infect Dis; 2009 May; 48 Suppl 4():S254-9. PubMed ID: 19374581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden.
    Jacobsson G; Dashti S; Wahlberg T; Andersson R
    Scand J Infect Dis; 2007; 39(1):6-13. PubMed ID: 17366006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular epidemiology of nursing home-associated Staphylococcus aureus bacteremia.
    Lesse AJ; Mylotte JM
    Am J Infect Control; 2006 Dec; 34(10):642-50. PubMed ID: 17161739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections].
    Bernard P; Jarlier V; Santerre-Henriksen A
    Ann Dermatol Venereol; 2008 Jan; 135(1):13-9. PubMed ID: 18342068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.